EXHIBIT 99-1


                           ACCUIMAGE DIAGNOSTICS CORP.
                               400 GRANDVIEW DRIVE
                          SOUTH SAN FRANCISCO, CA 94080
                               STOCK SYMBOL: AIDP


FOR IMMEDIATE RELEASE


ACCUIMAGE ANNOUNCES CHANGES ON ITS BOARD OF DIRECTORS
SOUTH SAN FRANCISCO, CALIF. - MARCH 19, 2002 -

     AccuImage  Diagnostics  Corp.  announced  that Dr. Douglas Boyd has retired
from the AccuImage Board of Directors. Concurrently, Dr. Julius R. Krevans, M.D.
and Dr.  Louis J.  Kearn,  Ph.D.  have  joined the Board.  Dr. C. Allen Wall was
elected as Chairman of the Board to replace Dr. Boyd.

Dr.  Krevans was the fifth  chancellor  of the  University  of  California,  San
Francisco  (UCSF).  During his tenure,  UCSF experienced many  achievements.  In
1989, UCSF applauded its first Nobel Prize winners, J. Michael Bishop and Harold
Varmus. UCSF also played a critical role in spawning the biotechnology  industry
during these years. Under Dr. Krevans' leadership, UCSF attracted many women and
minority  students  to careers in health  sciences.  Before his  appointment  as
chancellor,  Dr.  Krevans  served as Dean of the School of Medicine at UCSF from
1971-1982.  He was also active on the boards and committees of numerous national
foundations,  government  agencies,  and  organizations  including  the National
Academy of Science's  Institute  of Medicine and the American  Board of Internal
Medicine. He served as the chair of the Association of American Medical Colleges
from 1980-81,  helping to develop  public policy for this  organization.  He was
also a director of the Clinical  Scholar  program,  a director of both the James
Picker and Bank of America-Giannini  Foundation, and a member of the Association
of American Physicians.

Dr. Louis J. Kearn holds a Ph.D. in Business  Administration from the University
of San Francisco. He is Founder and Chairman, Emeritus, of COIT Services, one of
the largest  drapery and carpet cleaning  companies in the United States.  He is
also the founder of the Kearn Family Research Center of Retinal  Degeneration at
the University of California, San Francisco Medical Center.

In  announcing  these  changes,  Dr. Leon  Kaufman,  AccuImage  CEO said "We are
saddened by the loss of Dr.  Boyd,  who has brought us valuable  scientific  and
business  insights,  and who has guided this  company  since its  inception.  He
remains  a  close  and  trusted  friend  of  the  company  as  well  as a  major
shareholder.   In  Dr.  Krevans  we  have  a  friend  and  uniquely  experienced
individual,  and we are honored by his willingness to serve on this Board. Under
Dr. Krevans as Dean and Chancellor at UCSF, the university saw unprecedented and
unsurpassed growth, not just in quantity,  but more importantly,  in quality and
importance.  Dr. Krevans is a knowledgeable physician and a superb administrator
and judge of people. Dr. Kearn is a successful  businessman and a man interested
in what technology can bring to human  well-being.  These two individuals  bring
competence  and  integrity to the Board,  and we hope that some of their "magic"
will rub off on us through their contributions", Dr. Kaufman concluded.


<PAGE>


     AccuImage is engaged in the development,  marketing and support of software
for visualization, analysis and management of medical imaging data, particularly
in support of the imaging screening market, a market that is growing even faster
than the traditional  imaging market.  The software brings value by reducing the
time the  physician  needs for  reviewing  and  reporting  cases,  enhancing the
interpretation of studies, and providing 3-D images for marketing, promotion and
patient  information.  Efficiency  gains and cost savings are  realized  through
automated  reporting  tools  incorporating  expert  knowledge,  and by providing
hardware and software  for  distribution  of the images and reports via internal
networks as well as internet  transmission  to remote  locations,  to  referring
physicians and to patients.  The Company is now expanding its markets  through a
three-pronged  approach:  the generation of automated report  generators for new
applications,  including  whole body  screening;  the sale of  upgrades  and new
products  to  existing  customers;   and  the  provision  of  quality  assurance
accreditation support services needed for demonstrating compliance with upcoming
recommendations  from the American  College of Radiology  and other  accrediting
bodies.   For  company   information  please  visit  the  AccuImage  website  at
www.accuimage.com.
_________________


     Except  for  the  historical  information  contained  herein,  the  matters
discussed in this news release may contain  forward-looking  statements that are
based  on  current  expectations  and  estimates  about  the  industry  in which
AccuImage operates,  the estimated impact of certain technological  advances, as
well as management's  beliefs and assumptions.  It is important to note that the
Company's  actual results could differ  materially  from those projected in such
forward-looking  statements.  The  factors  that could cause  actual  results to
differ  materially  include,  among  others:  reliance on product  distributors;
competition  in the  diagnostic  imaging  market;  failure  to  improve  product
reliability or introduce new product models and enhancements;  determinations by
regulatory  and  administrative  government  authorities;  and the risk  factors
listed from time to time in the  Company's  Securities  and Exchange  Commission
reports.

CONTACT:
    AccuImage Diagnostics Corp. 650/875-0192 www.accuimage.com
                                             _________________
    Investor Relations: investors@accuimage.com
                        _______________________
    Leon Kaufman, Ph.D., CEO contact@accuimage.com
                             _____________________